EIT Health, part of the European Institute of Innovation and Technology (EIT), a body of the European Union, celebrates its recognition by UBI Global as the world’s leading Public|Private Business Accelerator.
Jean-Marc Bourez, CEO of EIT Health, stated: "On behalf of everyone at EIT Health, I am immensely proud of this outstanding result. First and foremost, I would like to acknowledge the efforts of everyone involved, especially the Business Creation and InvestHealth Team, who dedicated considerable time to gathering the data and insights necessary to showcase our work and secure our position as the No. 1 Public/Private Business Accelerator. Our accelerator programmes offer a tailored suite of tools and services, providing best-in-class support to start-ups and SMEs as they navigate our access to finance tools and secure a variety of investments. By collaborating with our partners, who possess in-depth market knowledge and expertise in navigating regulatory pathways, we are able to shorten the time to market for life-changing health products and services that will ultimately transform patients' lives and positively impact health outcomes. Since launching our first programmes, we have supported over 1,300 start-ups and facilitated investments totalling more than €3 billion – figures that attest to both the strength and success of EIT Health - InvestHealth in this field over the past seven years."
UBI Global, the Stockholm-based innovation intelligence company and community known for the assessment and mapping of business incubators and accelerators, released the top lists and top challengers as assessed by the World Benchmark Study 2022-2023.
"Following a rigorous data-driven approach, we assessed and benchmarked incubation organisations across the world,” says Joshuah Sowah, Head of Research at UBI Global. ”Our study is in tune with the multiple facets of the international incubation ecosystem and illustrates critical challenges and opportunities the participating organisations face.".
This article was first published on 17 May by EIT Health.